Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neurosci ; 44(29)2024 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-38830764

RESUMO

Human genetics and preclinical studies have identified key contributions of TREM2 to several neurodegenerative conditions, inspiring efforts to modulate TREM2 therapeutically. Here, we characterize the activities of three TREM2 agonist antibodies in multiple mixed-sex mouse models of Alzheimer's disease (AD) pathology and remyelination. Receptor activation and downstream signaling are explored in vitro, and active dose ranges are determined in vivo based on pharmacodynamic responses from microglia. For mice bearing amyloid-ß (Aß) pathology (PS2APP) or combined Aß and tau pathology (TauPS2APP), chronic TREM2 agonist antibody treatment had limited impact on microglia engagement with pathology, overall pathology burden, or downstream neuronal damage. For mice with demyelinating injuries triggered acutely with lysolecithin, TREM2 agonist antibodies unexpectedly disrupted injury resolution. Likewise, TREM2 agonist antibodies limited myelin recovery for mice experiencing chronic demyelination from cuprizone. We highlight the contributions of dose timing and frequency across models. These results introduce important considerations for future TREM2-targeting approaches.


Assuntos
Doença de Alzheimer , Glicoproteínas de Membrana , Microglia , Esclerose Múltipla , Receptores Imunológicos , Animais , Receptores Imunológicos/agonistas , Receptores Imunológicos/metabolismo , Receptores Imunológicos/genética , Glicoproteínas de Membrana/agonistas , Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/metabolismo , Camundongos , Esclerose Múltipla/tratamento farmacológico , Esclerose Múltipla/imunologia , Feminino , Masculino , Microglia/efeitos dos fármacos , Microglia/metabolismo , Modelos Animais de Doenças , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Anticorpos/farmacologia , Humanos , Peptídeos beta-Amiloides/metabolismo , Proteínas tau/metabolismo
2.
Cell Rep ; 40(8): 111189, 2022 08 23.
Artigo em Inglês | MEDLINE | ID: mdl-36001972

RESUMO

Oligodendrocyte dysfunction has been implicated in the pathogenesis of neurodegenerative diseases, so understanding oligodendrocyte activation states would shed light on disease processes. We identify three distinct activation states of oligodendrocytes from single-cell RNA sequencing (RNA-seq) of mouse models of Alzheimer's disease (AD) and multiple sclerosis (MS): DA1 (disease-associated1, associated with immunogenic genes), DA2 (disease-associated2, associated with genes influencing survival), and IFN (associated with interferon response genes). Spatial analysis of disease-associated oligodendrocytes (DAOs) in the cuprizone model reveals that DA1 and DA2 are established outside of the lesion area during demyelination and that DA1 repopulates the lesion during remyelination. Independent meta-analysis of human single-nucleus RNA-seq datasets reveals that the transcriptional responses of MS oligodendrocytes share features with mouse models. In contrast, the oligodendrocyte activation signature observed in human AD is largely distinct from those observed in mice. This catalog of oligodendrocyte activation states (http://research-pub.gene.com/OligoLandscape/) will be important to understand disease progression and develop therapeutic interventions.


Assuntos
Doenças Desmielinizantes , Esclerose Múltipla , Doenças Neurodegenerativas , Animais , Cuprizona/uso terapêutico , Doenças Desmielinizantes/patologia , Modelos Animais de Doenças , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Esclerose Múltipla/genética , Esclerose Múltipla/patologia , Doenças Neurodegenerativas/genética , Doenças Neurodegenerativas/patologia , Oligodendroglia
3.
J Clin Toxicol ; 6(3)2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28255523

RESUMO

CONTEXT: Hypotension is one of the dose limiting side effects of benzodiazepines (BZDs), in particular of diazepam (DZP) which is still widely used in the clinic. Currently, only one FDA approved antidote exists for BZD overdose and novel approaches are needed to improve management of DZP overdose, dependency and withdrawal. OBJECTIVE: Here, we hypothesized that increasing bioactive lipid mediators termed epoxy fatty acids (EpFAs) will prevent hypotension, as was shown previously in a murine model of LPS-induced hypotension. Therefore, we first characterized the time and dose dependent profile of DZP induced hypotension in mice, and then investigated the reversal of the hypotensive effect by inhibiting the soluble epoxide hydrolase (sEH), an enzyme that regulates the levels of EpFAs. MATERIALS AND METHODS: Following baseline systolic BP recording using tail cuffs, mice were administered a sEH inhibitor (TPPU) before DZP and BP was monitored. Blood and brain levels of DZP and TPPU were quantified to examine distribution and metabolism. Plasma EpFAs levels were quantified to determine TPPU target engagement. RESULTS: In this murine model, DZP induced dose dependent hypotension which was more severe than midazolam. The temporal profile was consistent with the reported pharmacokinetics/pharmacodynamics of DZP. Treatment with TPPU reversed the hypotension resulting from high doses of DZP and decreased the sEH metabolites of EpFAs in the plasma demonstrating target engagement. DISCUSSION AND CONCLUSION: Overall, these findings demonstrate the similarity of a murine model of DZP induced hypotension to clinical observations in humans. Furthermore, we demonstrate that stabilization of EpFAs by inhibiting sEH is a novel approach to overcome DZP-induced hypotension and this beneficial effect can be enhanced by an omega three diet probably acting through epoxide metabolites of the fatty acids.

4.
Neuropharmacology ; 95: 332-42, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25882826

RESUMO

Tetramethylenedisulfotetramine (TETS) is a potent convulsant GABAA receptor blocker. Mice receiving a lethal dose of TETS (0.15 mg/kg i.p.) are rescued from death by a high dose of diazepam (5 mg/kg i.p.) administered shortly after the second clonic seizure (∼20 min post-TETS). However, this high dose of diazepam significantly impairs blood pressure and mobility, and does not prevent TETS-induced neuroinflammation in the brain. We previously demonstrated that TETS alters synchronous Ca(2+) oscillations in primary mouse hippocampal neuronal cell cultures and that pretreatment with the combination of diazepam and allopregnanolone at concentrations having negligible effects individually prevents TETS effects on intracellular Ca(2+) dynamics. Here, we show that treatment with diazepam and allopregnanolone (0.1 µM) 20 min after TETS challenge normalizes synchronous Ca(2+) oscillations when added in combination but not when added singly. Similarly, doses (0.03-0.1 mg/kg i.p.) of diazepam and allopregnanolone that provide minimal protection when administered singly to TETS intoxicated mice increase survival from 10% to 90% when given in combination either 10 min prior to TETS or following the second clonic seizure. This therapeutic combination has negligible effects on blood pressure or mobility. Combined treatment with diazepam and allopregnanolone also decreases TETS-induced microglial activation. Diazepam and allopregnanolone have distinct actions as positive allosteric modulators of GABAA receptors that in combination enhance survival and mitigate neuropathology following TETS intoxication without the adverse side effects associated with high dose benzodiazepines. Combination therapy with a benzodiazepine and neurosteroid represents a novel neurotherapeutic strategy with potentially broad application.


Assuntos
Anticonvulsivantes/farmacologia , Cálcio/metabolismo , Diazepam/farmacologia , Pregnanolona/farmacologia , Convulsões/tratamento farmacológico , Animais , Hidrocarbonetos Aromáticos com Pontes , Células Cultivadas , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Quimioterapia Combinada , Hipocampo/efeitos dos fármacos , Hipocampo/patologia , Hipocampo/fisiopatologia , Masculino , Camundongos , Neuroimunomodulação/efeitos dos fármacos , Neuroimunomodulação/fisiologia , Neurônios/efeitos dos fármacos , Neurônios/patologia , Neurônios/fisiologia , Convulsões/patologia , Convulsões/fisiopatologia
5.
Toxicol Appl Pharmacol ; 281(2): 185-94, 2014 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-25448683

RESUMO

Tetramethylenedisulfotetramine (TETS) is a potent convulsant poison for which there is currently no approved antidote. The convulsant action of TETS is thought to be mediated by inhibition of type A gamma-aminobutyric acid receptor (GABAAR) function. We, therefore, investigated the effects of post-exposure administration of diazepam, a GABAAR positive allosteric modulator, on seizure activity, death and neuroinflammation in adult male Swiss mice injected with a lethal dose of TETS (0.15mg/kg, ip). Administration of a high dose of diazepam (5mg/kg, ip) immediately following the second clonic seizure (approximately 20min post-TETS injection) effectively prevented progression to tonic seizures and death. However, this treatment did not prevent persistent reactive astrogliosis and microglial activation, as determined by GFAP and Iba-1 immunoreactivity and microglial cell morphology. Inhibition of soluble epoxide hydrolase (sEH) has been shown to exert potent anti-inflammatory effects and to increase survival in mice intoxicated with other GABAAR antagonists. The sEH inhibitor TUPS (1mg/kg, ip) administered immediately after the second clonic seizure did not protect TETS-intoxicated animals from tonic seizures or death. Combined administration of diazepam (5mg/kg, ip) and TUPS (1mg/kg, ip, starting 1h after diazepam and repeated every 24h) prevented TETS-induced lethality and influenced signs of neuroinflammation in some brain regions. Significantly decreased microglial activation and enhanced reactive astrogliosis were observed in the hippocampus, with no changes in the cortex. Combining an agent that targets specific anti-inflammatory mechanisms with a traditional antiseizure drug may enhance treatment outcome in TETS intoxication.


Assuntos
Anti-Inflamatórios/administração & dosagem , Anticonvulsivantes/administração & dosagem , Encéfalo/efeitos dos fármacos , Hidrocarbonetos Aromáticos com Pontes , Diazepam/administração & dosagem , Encefalite/prevenção & controle , Inibidores Enzimáticos/administração & dosagem , Epóxido Hidrolases/antagonistas & inibidores , Moduladores GABAérgicos/administração & dosagem , Compostos de Fenilureia/administração & dosagem , Piperidinas/administração & dosagem , Convulsões/prevenção & controle , Animais , Encéfalo/enzimologia , Encéfalo/fisiopatologia , Ondas Encefálicas/efeitos dos fármacos , Modelos Animais de Doenças , Esquema de Medicação , Quimioterapia Combinada , Eletroencefalografia , Encefalite/induzido quimicamente , Encefalite/enzimologia , Encefalite/fisiopatologia , Epóxido Hidrolases/metabolismo , Masculino , Camundongos , Convulsões/induzido quimicamente , Convulsões/enzimologia , Convulsões/fisiopatologia , Fatores de Tempo
6.
J Exp Biol ; 214(Pt 13): 2237-41, 2011 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-21653817

RESUMO

In this study we tested the hypothesis that a viscous thread releases its hold on a surface because its glycoprotein glue pulls from the surface and not because its elongating droplets break near their attachment to the surface. We compared the values obtained when three species' viscous threads adhered to four smooth surfaces, which differed in their total surface energy and in the proportions of their dispersion and polar energy components. Although water comprised 43-70% of the volume of these viscous droplets, only the dispersion surface energies of test materials and not their polar surface energies impacted thread adhesion. These results support the droplet pull-off hypothesis and are consistent with a previous finding that capillary force contributes little to thread adhesion. Just as a viscous thread's stickiness is constrained by the tensile strength of its supporting axial fibers, our findings suggest that glycoprotein adhesion is constrained by glycoprotein tensile strength.


Assuntos
Glicoproteínas/química , Seda/fisiologia , Aranhas/fisiologia , Adesividade , Animais , Feminino , Modelos Biológicos , Seda/química , Especificidade da Espécie , Propriedades de Superfície , Resistência à Tração , Viscosidade
7.
J Exp Zool A Ecol Genet Physiol ; 311(3): 217-25, 2009 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-19199347

RESUMO

The spirally arrayed viscous capture threads of spider orb-webs are formed of small, regularly spaced adhesive droplets and are responsible for retaining insects that strike the web, giving a spider more time to subdue these prey. These sticky threads are deposited from the perimeter of the web inward. We tested the hypothesis that depletion of silk reserves during web construction affects the properties of capture threads spun by adult female Argiope aurantia and Argiope trifasciata. In both species the droplet volume (DV) per millimeter thread length was the same in outer and inner capture threads and in early and late season webs. However, the outer threads of both species were stickier than their inner threads and, consequently, had a greater stickiness per DV. Thus, dwindling silk reserves during web construction appeared to reduce the stickiness of both species' threads by changing the composition rather than the volume of their viscous droplets. In A. trifasciata, which we studied later in the fall than A. aurantia, there were also seasonal declines in both thread stickiness and stickiness per DV, which may result from either the depletion of silk reserves or the reallocation of these resources. Early season webs of A. trifasciata also had greater stickiness per square centimeter of capture area than late season webs, better equipping these early webs to retain insects.


Assuntos
Fibroínas/fisiologia , Aranhas/fisiologia , Animais , Feminino , Fibroínas/metabolismo , Comportamento Predatório/fisiologia , Estações do Ano , Aranhas/metabolismo , Viscosidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...